| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Clindamycin 1% with tretinoin 0.025% |
| Brand | Treclinac® |
| Indication | For the topical treatment of acne vulgaris when comedones, papules and pustules are present in patients 12 years or older. |
| Assessment Process | |
| Rapid review commissioned | 08/04/2014 |
| Rapid review completed | 06/05/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |